GLG News by Emergency Medicine Physicians (US)

The study was presented at the AHA Meeting.  Statistics were presented on 3 of the most prescribed NSAIDS.  A comment regarding the high number of 'Comlications' when Plavix was given with a PPI.

No impact, because any legislation involved can be rewritten if the legislators disagree with the Supreme Court decision!

They've promised only to disclose payments OVER $500.00, so they can pay people 499.99 multiple times and never report!

The Stark bill aims to offer both incentives and eventually financial penalties to speed the adoption of electronic medical records. It includes provisions that would create a "standard", however it is unclear the degree of interoperability different systems would have, and the degree to which the interfaces...

We do not know enough about the effects of statins over a lifetime to justify use in children. Maybe we would reduce cardiovascular mortality, maybe not.  But at what cost?  I'm talking about both financial costs and the health costs related to drug side effects.  We need a lot more information...

Calling a 0.89% improvement "significant" just seems to me to show the weakness of this current trial.  Anyone can use statistics to prove just about anything.  Using verbal manipulation to puff up a study's result is unfair, unreliable and just plain sad.

When the new administration come in, medicine and big pharma are both going to be hit hard.  Industry sponsored research is going to be examined with a fine tooth comb.  All we need is another scandal.  It's getting harder and harder to trust industry sponsored research, with news coming...

Percutaneous coronary interventions are standard therapy for both acute MI patients as well as unstable coronary syndromes, and are commonly utilized as preventive therapy in some patients. The practice of thrombectomy prior to stenting in these patients is simple and fairly risk-free, but...

To be successful enrollment will have to be done in a mildly involuntary mannner. ie "You will be enrolled but can opt out by doing xyz." The ultimate test of such plans will be the willing acceptance by patients of disease management programs. Occasional inducements such as discounts...

The reason that 19 percent of Physicians refuse to see Sales Reps for Pharmaceutical, Biotech or Medical devices is easy, it's all about money. Many physicians are feeling the loss of income with higher overhead and less reimbursement. To compensate for this loss of income they schedule more patients...